In addition, natural compound HCD and its successor MSN-HCD improved insulin resistance and promoted metabolism to control body weight as a valuable method, suggesting that they have the potential to develop as hypoglycemic drugs for diabetes therapy via DPP4 inhibition. The gene discussed is DPP4; the disease is diabetes mellitus.